These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34275705)

  • 1. In vivo anticancer effects of Momordica charantia seed fat on hepatocellular carcinoma in a rat model.
    Ranasinghe KNK; Premarathna AD; Mahakapuge TAN; Wijesundera KK; Ambagaspitiya AT; Jayasooriya AP; Kularatne SAM; Rajapakse RPVJ
    J Ayurveda Integr Med; 2021; 12(3):435-442. PubMed ID: 34275705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pomegranate seed oil and bitter melon aqueous extract on polyunsaturated fatty acids and their lipoxygenase metabolites concentration in serum of rats.
    Białek A; Jelińska M; Tokarz A; Pergół A; Pinkiewicz K
    Prostaglandins Other Lipid Mediat; 2016 Nov; 126():29-37. PubMed ID: 27418544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse roles of bitter melon (
    Sur S; Ray RB
    J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34765739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Peroxisome Proliferator-Activated Receptor α in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of α-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.
    Chang YY; Su HM; Chen SH; Hsieh WT; Chyuan JH; Chao PM
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components.
    Chen GC; Chen WH; Tseng KT; Chao PM
    Lipids Health Dis; 2017 Sep; 16(1):186. PubMed ID: 28962621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pomegranate Seed Oil and Bitter Melon Extract Affect Fatty Acids Composition and Metabolism in Hepatic Tissue in Rats.
    Stawarska A; Lepionka T; Białek A; Gawryjołek M; Bobrowska-Korczak B
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33182664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of acute and sub-chronic toxicity of bitter melon seed extract in Wistar rats.
    Chung WY; Jadhav S; Hsu PK; Kuan CM
    Toxicol Rep; 2022; 9():1024-1034. PubMed ID: 36518426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
    Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
    Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
    Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
    Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apoptosis mechanisms of HepG2 cells induced by bitter melon seed.
    Cao QG; Guo Q; Bai J; Dong Y; Zhang XH; Hong WL
    J Food Biochem; 2021 May; 45(5):e13683. PubMed ID: 33844303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a soluble phosphatidic acid phosphatase in bitter melon (Momordica charantia).
    Cao H; Sethumadhavan K; Grimm CC; Ullah AH
    PLoS One; 2014; 9(9):e106403. PubMed ID: 25203006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bitter Melon (
    Sur S; Ray RB
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726914
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Bortolotti M; Mercatelli D; Polito L
    Front Pharmacol; 2019; 10():486. PubMed ID: 31139079
    [No Abstract]   [Full Text] [Related]  

  • 15. A conjugated fatty acid present at high levels in bitter melon seed favorably affects lipid metabolism in hepatocytes by increasing NAD(+)/NADH ratio and activating PPARα, AMPK and SIRT1 signaling pathway.
    Chen GC; Su HM; Lin YS; Tsou PY; Chyuan JH; Chao PM
    J Nutr Biochem; 2016 Jul; 33():28-35. PubMed ID: 27260465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
    Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
    Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (
    Hussain L; Aamir N; Hussain M; Asif M; Chauhdary Z; Manzoor F; Siddique R; Riaz M
    Evid Based Complement Alternat Med; 2022; 2022():5143653. PubMed ID: 36212951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.